4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-060908
Chief Science & Business Off bought 670 shares at an average $15.33 ($10,273)
From the SEC's structured data for this filing
Trades in this filing
Poradosu Enrique · Chief Science & Business Off
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-12 | Purchase : show line 1 in the form | +370 | $14.76 | $5,461 | 1,258,019 | D |
| 2022-05-12 | Purchase : show line 2 in the form | +300 | $16.04 | $4,812 | 1,258,319 | D |
| Open-market purchases · 670 sh · avg $15.33 · $10,273 | ||||||
Loading xslF345X03/tm2215423-1_4seq1.xml…